Prevalence and predictors of microalbuminuria in patients with type 2 diabetes mellitus: A cross-sectional observational study in Oman

Diabetes Research and Clinical Practice

Volumn 72, Issue 2, 2006, Pages 212-215

  Al Futaisi, Abdullah ^a   Al Zakwani, Ibrahim ^b   Almahrezi, Abdulaziz ^a   Al Hajri, Ruqaia ^a   Al Hashmi, Laila ^a   Al Muniri, Abdullah ^a   Farooqui, Mahfooz ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

Author keywords

Microalbuminuria; Oman; Predictors; Prevalence; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; FEMALE; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OMAN; OUTPATIENT; PREDICTION; PREVALENCE; RISK ASSESSMENT; TIME SERIES ANALYSIS;

ALBUMINURIA; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OMAN; PREVALENCE; RISK FACTORS;

EID: 33748054295     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2005.10.001     Document Type: Article

References (20)

1. The World Health Organization, The Diabetes Program 2004. Available at: http://www.who.int/diabetes/en. Accessed on May 31, 2005.
2. Nathan D.M. Long-term complications of diabetes mellitus. New Engl J Med 328 (1993) 1676-1685
3. Deckert T., Kofoed-Enevoldsen A., Norgaard K., Borch-Johnsen K., Feldt-Rasmussen B., and Jensen T. Microalbuminuria: implications for micro- and macro-vascular disease (Review Article). Diab Care 15 (1992) 1181-1191
4. JNC-7 High Blood Pressure Guidelines. Available at: http://www.ascp.com/public/pr/bloodpressure/jnc7/guidelines/. Accessed on May 2, 2005.
5. Viberti G.C., Mogensen C.E., Groop I., Pauls J.F., and The European Microalbuminuria Captopril Captopril Group. Effect of Captopril on progression to clinical proteinuria with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 271 (1994) 275-279
6. R.E. Klabunde, Cardiovascular Physiology Concepts: Mean Arterial Pressure, Available at: http://www.cvphysiology.com/Blood Pressure/BP006.htm. Accessed on March 29, 2005.
7. Hong C.Y., and Chia K.S. Markers of diabetic nephropathy. J Diab Complicat 12 (1998) 43-60
8. Rossing. Predictors of mortality in insulin-dependent diabetes: 10-year observational follow-up study. BMJ 313 (1996) 779-784
9. Ritz E. Albuminuria and vascular damage -- the vicious twins. N Engl J Med 348 (2003) 2349-2352
10. Gall M.A., Rossing P., Skott P., Damsbo P., Vaag A., Bech K., et al. Prevalence of micro- and macro-albuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34 (1991) 655-661
11. Al-Lawati J.A., Al Riyami A.M., Mohammed A.J., and Jousilahti P. Increasing prevalence of diabetes mellitus in Oman. Diab Med 19 (2002) 954-957
12. Weir M.R. Albuminuria prediction outcome in diabetes: incidence of microalbuminuria in Asia-Pacific rim. Kidney Int 66 (2004) S38-S39
13. Nelson R.G., Knowler W.C., Pettitt D.J., Saad M.F., Charles M.A., and Bennett P.H. Assessing risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens. Arch Intern Med 151 (1991) 1761-1765
14. Microalbuminuria Collaborative Study Group. Effect of Captopril on progression to clinical proteinuria with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 271 (1994) 275-279
15. Ravid M., Brosh D., Ravid-Safran D., Levy Z., and Rachmani R. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 158 (1998) 998-1004
16. Gerstein H.C., Mann J.F.E., Pogue J., et al. Prevalence and determinants of microalbuminuria in high-risk diabetic and non-diabetic patients in the heart outcomes prevention evaluation study. Diab Care 23 S2 (2000) B35-B39
17. Comper W.D., Osicka T.M., Clark M., MacIsaac R.J., and Jerums G. Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay. Kidney Int 65 (2004) 1850-1855
18. Young B.A., Katon W.J., Von Korff M., Simon G.E., Lin E.H.B., Ciechanowski P.S., et al. Racial and ethnic differences in microalbuminuria prevalence in diabetes population: the pathways study. J Am Soc Nephrol 16 (2005) 219-228
19. Verhave J.C., Gansevoort R.D., Hillege H.L., et al. An elevated urinary excretion predicts denovo development of renal function impairment in the general population. Kidney Int 66 92 (2004) S18-S21
20. Molnar M., Wittman I., and Nagy J. Prevalence, course and risk factors of diabetic nephropathy in type 2 diabetes mellitus. Med Sci Monit 6 (2000) 929-936